Home  >  R & D  >  details

PHN014 (Acute ischemia stroke)

PhytoHealth PHN014 is an injection that was developed using extracted, isolated, and highly purified active polysaccharides from the herb Astragalus (Huang-qi) and is commonly used in traditional Chinese medicine as an immunostimulant that is known to be “yi qi bu xu” (beneficial to the energy flow, and can cure deficiencies in the body). The results of animal and in vitro testing showed that PhytoHealth PHN014 has the functionality of stimulating bone marrow hematopoiesis, regulating the immune system, preventing oxidization and inflammation, facilitating the activation of granulocyte-colony stimulating factor (G-CSF), and driving and activating stem cell development. Therefore, PhytoHealth PHN014 has the potential to be used for the treatment of acute ischemic stroke. A large scale, multi-center clinical trial on human subjects has been conducted among fifteen medical centers, such as the National Taiwan University Hospital and China Medical University Hospital, to test the product. The clinical study report has been completed. Other relevant data analysis will be further examined for the next stage of drug development.

Notable achievements


The industry-university cooperative research project with the「Stroke Excellence Clinical Trials and Research Center」in China Medical university hospital


It’s the achievement for“Industry-University link innovative research room”which be built together.